These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 34281544)

  • 41. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
    Chang X; Lv YF; He J; Cao Y; Li CQ; Guo QN
    J Hepatocell Carcinoma; 2021; 8():85-101. PubMed ID: 33738268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
    Wu J; Wang X; Xu H; Tian J; Ji H; Zhu J; Guo H; Chen Z
    Ann Transl Med; 2022 Dec; 10(24):1386. PubMed ID: 36660722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
    Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
    J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
    Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
    Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
    [No Abstract]   [Full Text] [Related]  

  • 47. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
    Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
    Front Immunol; 2022; 13():950365. PubMed ID: 36159855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model.
    Li J; Zuo Z; Lai S; Zheng Z; Liu B; Wei Y; Han T
    J Gastrointest Oncol; 2021 Aug; 12(4):1384-1397. PubMed ID: 34532096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma.
    Yang H; Liu J; Li L; Wang X; Li Z
    Transl Cancer Res; 2024 Jan; 13(1):381-393. PubMed ID: 38410211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
    Tang J; Wan Q; Lu J
    BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. m
    Su Y; Huang J; Hu J
    Front Oncol; 2019; 9():1038. PubMed ID: 31681576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy.
    Xia M; Wang S; Ye Y; Tu Y; Huang T; Gao L
    Front Immunol; 2022; 13():995645. PubMed ID: 36389678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer.
    Han H; Fu X; Zhang Y; Luo D; Zhang X; Wu X
    Iran J Public Health; 2023 Sep; 52(9):1902-1916. PubMed ID: 38033847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA m6A Methylation Regulators Multi-Omics Analysis in Prostate Cancer.
    Su H; Wang Y; Li H
    Front Genet; 2021; 12():768041. PubMed ID: 34899855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
    Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
    Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma.
    Zhao Z; Yang L; Fang S; Zheng L; Wu F; Chen W; Song J; Chen M; Ji J
    Front Oncol; 2020; 10():1435. PubMed ID: 32974160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
    Zhang W; Wang L; Zhang P; Zhang Q
    Medicine (Baltimore); 2021 May; 100(20):e25952. PubMed ID: 34011074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.